131 related articles for article (PubMed ID: 34533756)
21. Predictive value of
Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET.
Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
Ann Thorac Surg; 2021 Jul; 112(1):264-270. PubMed ID: 33058828
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S; Ichiyasu H; Ikeda T; Inaba M; Kashiwabara K; Sadamatsu T; Sato N; Akaike K; Okabayashi H; Saruwatari K; Tomita Y; Saeki S; Hirata N; Yoshinaga T; Fujii K
BMC Pulm Med; 2019 Apr; 19(1):72. PubMed ID: 30940113
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for acute exacerbation of idiopathic interstitial pneumonia in patients undergoing lung cancer treatment.
Taya T; Chiba H; Yamada G; Takahashi M; Ikeda K; Mori Y; Otsuka M; Takahashi H
Jpn J Clin Oncol; 2019 Dec; 49(12):1126-1133. PubMed ID: 31411689
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
Respir Med; 2019; 154():122-126. PubMed ID: 31238182
[TBL] [Abstract][Full Text] [Related]
26. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
[TBL] [Abstract][Full Text] [Related]
27. [Surgical Treatment and Postoperative Management in Lung Cancer Patients with Interstitial Lung Disease].
Imai K; Minamiya Y
Kyobu Geka; 2020 Sep; 73(10):840-844. PubMed ID: 33130776
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
29. A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.
Okamoto M; Fujimoto K; Sadohara J; Furuya K; Kaieda S; Miyamura T; Suematsu E; Kitasato Y; Kawayama T; Ida H; Ichiki M; Hoshino T
Respir Investig; 2016 Nov; 54(6):445-453. PubMed ID: 27886856
[TBL] [Abstract][Full Text] [Related]
30. Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer.
Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
Thorac Cancer; 2021 Mar; 12(5):667-675. PubMed ID: 33480111
[TBL] [Abstract][Full Text] [Related]
31. Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.
Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
Thorac Cancer; 2021 Jun; 12(11):1681-1689. PubMed ID: 33939332
[TBL] [Abstract][Full Text] [Related]
32. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
[TBL] [Abstract][Full Text] [Related]
33. Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy.
Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Takahashi T
J Cancer; 2018; 9(11):2054-2060. PubMed ID: 29896291
[No Abstract] [Full Text] [Related]
34. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.
Suda T; Kaida Y; Nakamura Y; Enomoto N; Fujisawa T; Imokawa S; Hashizume H; Naito T; Hashimoto D; Takehara Y; Inui N; Nakamura H; Colby TV; Chida K
Respir Med; 2009 Jun; 103(6):846-53. PubMed ID: 19181509
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in surgically managed non-small-cell lung cancer patients with evidence of interstitial pneumonia identified on preoperative radiology or incidentally on postoperative histology.
Maniwa T; Kondo H; Mori K; Sato T; Teramukai S; Ebina M; Kishi K; Watanabe A; Sugiyama Y; Date H
Interact Cardiovasc Thorac Surg; 2015 May; 20(5):641-6. PubMed ID: 25712985
[TBL] [Abstract][Full Text] [Related]
36. A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery.
Ito H; Nakayama H; Yokose T; Nagashima T; Morohoshi T; Tajiri M; Maehara T; Watanabe K; Arai H; Yamamoto T; Woo T; Nishii T; Ishikawa Y; Morita S; Masuda M
Jpn J Clin Oncol; 2020 Feb; 50(2):198-205. PubMed ID: 31917421
[TBL] [Abstract][Full Text] [Related]
37. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
Sato T; Teramukai S; Kondo H; Watanabe A; Ebina M; Kishi K; Fujii Y; Mitsudomi T; Yoshimura M; Maniwa T; Suzuki K; Kataoka K; Sugiyama Y; Kondo T; Date H;
J Thorac Cardiovasc Surg; 2014 May; 147(5):1604-1611.e3. PubMed ID: 24267779
[TBL] [Abstract][Full Text] [Related]
38. Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.
Kakiuchi S; Hanibuchi M; Tezuka T; Saijo A; Otsuka K; Sakaguchi S; Toyoda Y; Goto H; Kawano H; Azuma M; Ogushi F; Nishioka Y
Respir Investig; 2017 Mar; 55(2):145-152. PubMed ID: 28274530
[TBL] [Abstract][Full Text] [Related]
39. Chest-tube drainage is a sign of acute exacerbation of interstitial lung disease associated with lung cancer.
Maniwa T; Isaka M; Nakagawa K; Ohde Y; Okumura T; Endo M; Kondo H
Surg Today; 2013 Apr; 43(4):408-11. PubMed ID: 23180119
[TBL] [Abstract][Full Text] [Related]
40. A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease.
Kamiya H; Panlaqui OM
BMC Pulm Med; 2021 May; 21(1):150. PubMed ID: 33952218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
